“…This may be achieved either by chemical methods [ 9 , 10 , 11 ], or by biotechnological ones. The effective enantioselectivity of the desired product was achieved either by using whole cells of biocatalysts [ 12 , 13 , 14 , 15 , 16 ] or with the help of isolated enzymes, such as dehydrogenases [ 1 , 17 , 18 ] and lipases [ 19 ]. Although in the majority of the reported studies, the halohydrins were obtained with high substrate conversions and high enantiomeric excesses, there is always a risk of side products due to reductive dehalogenation (leading to respective 1-phenylehtan-1,2-diols) and substitution (2-hydroxyacetophenone and 1-phenylehtan-1,2-diol) [ 20 , 21 ].…”